Literature DB >> 31252

Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.

A Rubinstein, K M Das, J Melamed, R A Murphy.   

Abstract

Comparative analysis of the systemic immunity revealed similarities between ulcerative colitis and idiopathic proctitis. In the active stage of both diseases, circulating complement receptor positive cells were increased whereas T-cell percentages and lymphocyte functions were decreased. In severe forms of ulcerative colitis and idiopathic proctitis circulating EAC-phagocytosing esterase positive cells, indicative of activated monocytes, were demonstrated. Successful treatment with salicylazosulfapyridine (SASP) reversed these immunological changes. Incubation of SASP and its metabolites with leucocytes from patients and control subjects, in concentrations similar to those demonstrated in sera from patients treated with SASP, did not alter the immunological changes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31252      PMCID: PMC1537567     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood.

Authors:  A G Ehlenberger; M McWilliams; J M Phillips-Quagliata; M E Lamm; V Nussenzweig
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

2.  Observations on idiopathic proctitis.

Authors:  J E LENNARD-JONES; G W COOPER; A C NEWELL; C W WILSON; F A JONES
Journal:  Gut       Date:  1962-09       Impact factor: 23.059

3.  Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide.

Authors:  M A Pellegrino; S Ferrone; M P Dierich; R A Reisfeld
Journal:  Clin Immunol Immunopathol       Date:  1975-01

4.  Macrophage neutral proteinases and chronic inflammation.

Authors:  S Gordon
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

5.  Immunohistochemical changes in morphologically involved and uninvolved colonic mucosa of patients with idiopathic proctitis.

Authors:  K M Das; W F Erber; A Rubinstein
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  Idiopathic proctitis. I. The morphology of proximal colonic mucosa and its clinical significance.

Authors:  K M Das; R Morecki; P Nair; J M Berkowitz
Journal:  Am J Dig Dis       Date:  1977-06

7.  Isolation and functional characterization of human intestinal mucosal lymphoid cells.

Authors:  D M Bull; M A Bookman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

9.  Macrophage plasminogen activator: induction by products of activated lymphoid cells.

Authors:  J D Vassalli; E Reich
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 4.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

5.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Authors:  C Wahl; S Liptay; G Adler; R M Schmid
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Sulphasalazine in rheumatoid arthritis: an old drug revived.

Authors:  V C Neumann; K A Grindulis
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

Review 7.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

8.  Antihelper T cell autoantibody in acquired agammaglobulinemia.

Authors:  A Rubinstein; M Sicklick; V Mehra; F S Rosen; R H Levey
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  Effects of sulfasalazine on selected lymphocyte subpopulations in vivo and in vitro.

Authors:  W R Thayer; C Charland; C E Field
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

10.  Increased suppressor cell activity in inflammatory bowel disease.

Authors:  G Holdstock; B F Chastenay; E L Krawitt
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.